HemaSphere (May 2023)

P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL

  • I. Ntanasis-Stathopoulos,
  • M. Gavriatopoulou,
  • P. Malandrakis,
  • D. Fotiou,
  • N. Kanellias,
  • M. Migkou,
  • F. Theodorakakou,
  • V. Spiliopoulou,
  • R. Syrigou,
  • E. Eleutherakis-Papaiakovou,
  • S. Gkolfinopoulos,
  • K. Manousou,
  • E. Kastritis,
  • M.A. Dimopoulos,
  • E. Terpos

DOI
https://doi.org/10.1097/01.HS9.0000936184.12325.62
Journal volume & issue
Vol. 7, no. S2
pp. 17 – 18

Abstract

Read online

No abstracts available.